Document is current
Any future updates will be listed below
-
Authors
Wang, Pin https://orcid.org/0000-0002-8031-8494
Asare, Ernest https://orcid.org/0000-0003-4078-8755
Pitzer, Virginia E. https://orcid.org/0000-0003-1015-2289
Dubrow, Robert https://orcid.org/0000-0002-5071-7742
Chen, Kai https://orcid.org/0000-0002-0164-1112
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI112970)
High Tide Foundation
Reckitt Global Hygiene Institute
- License Information
-
More Information
Article History
Received: 20 January 2022
Accepted: 13 June 2022
First Online: 30 June 2022
Ethics approval
: This study was determined by the Yale Institutional Review Board as not-human-subject research (IRB ID: 2000030174) and thus ethics approval was not required for the current study.
: V.E.P. has received reimbursement from Merck and Pfizer for travel to Scientific Input Engagements unrelated to the topic of this study and is a member of the WHO Immunization and Vaccine-related Implementation Research Advisory Committee (IVIR-AC). The remaining authors declare no competing interests.
